Hisakazu Ohtani

8PUBLICATIONS
16CO-AUTHORS
Pharmaceutical delivery technologiesDeep learningTraditional Chinese medicine and treatmentsMolecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 03, 2026
Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report.

|Mar 07, 2025
Performance Improvement of a Natural Language Processing Tool for Extracting Patient Narratives Related to Medical States From Japanese Pharmaceutical Care Records by Increasing the Amount of Training Data: Natural Language Processing Analysis and Validation Study.

Yukiko Ohno, Tohru Aomori, Tomohiro Nishiyama

|Feb 27, 2025
Medication counseling for OTC drugs using customized ChatGPT-4: Comparison with ChatGPT-3.5 and ChatGPT-4o.

Keisuke Kiyomiya, Tohru Aomori, Hisakazu Ohtani

|Jul 29, 2023
Irinotecan-induced gastrointestinal damage alters the expression of peptide transporter 1 and absorption of cephalexin in rats.

Ayuko Imaoka, Tomoki Hattori, Takeshi Akiyoshi

|Jan 18, 2022
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.

Hideyuki Hibino, Naomi Sakiyama, Yoshinori Makino

|Jul 01, 2021
Digoxin absorption decreased independently of P-gp activity in rats with irinotecan-induced gastrointestinal damage.

Toshiaki Tsuchitani, Takeshi Akiyoshi, Ayuko Imaoka

Pageof 2

Frequent Collaborators

2 joint publications

Takeshi Akiyoshi

2 joint publications

Keisuke Kiyomiya

1 joint publications

Ayuko Imaoka

1 joint publications

Yukiko Ohno